Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07734467) titled 'Immune Response to PSF in Idiopathic vs Neuromuscular Scoliosis' on July 24.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Ambrish Patel
Condition:
Posterior Spinal Fusion
Idiopathic Scoliosis
Neuromuscular Scoliosis
Intervention:
Diagnostic Test: Serum blood samples for serum biomarkers of immune response
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 2026
Target Sample Size: 20
Countries of Recruitment:
United States
To know more, vi...